free statistics
 

First Name  Jeremy
Age diagnosed  50
 

Last Name   Bowyer
Age symptoms appeared  48


Years with Parkinson's at time of responses   16

GDNF Clinical Trial

Trial Center Location  [optional]   Frenchay Hospital Bristol

1.  In which clinical trial did you participate?     Phase II   

2.  For how long did you receive GDNF treatments?    9 months
 

[#3 - 5 for Phase II only]

3.  Did you receive a placebo for the first 6 months?    no

4.  If so, did you receive GDNF after the 6 month trial period ended?  NA

5.  If first given the placebo, how many GDNF treatments did you receive before the halt?    NA

6. Since starting the GDNF trial:

Did you notice any physical, cognitive or emotional changes in your Parkinson's Disease?
Please describe the changes and when you first noticed them.

My family noticed no difference but after about 6 months I began to notice a slight improvement. In particular I had several mornings when I woke up feeling well,  which had not been the case for at least 5 years.

7.  Since the trial halt in September 2004:

Did you notice any physical, cognitive or emotional changes in your Parkinson's Disease?
Please describe the changes and when you first noticed them.

I slowly lapsed back to the condition which prevailed before the start of the GDNF trial.

8. Are your pump and catheter(s) still implanted?    no

9. Have you had a DBS ?   yes

How well do you think the DBS worked?

It has been a great help in dealing with freezing and dyskinesia but my sense of balance and my lack of energy and strength are an increasing problem.

10.  Additional comments:

I was disappointed to learn, after the trial, that we had been given a dose about one third of that given to phase 1 patients. We should, as a matter of ethics, have been told this and we should have been allowed to continue the trial with an increased dose.

Copyright © 2004-2009 Parkinson Pipeline Project.

All rights reserved. Revised: 12/11/09.